By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Otsuka Pharmaceutical Co., Ltd. 

2-9 Kanda Tsukasa-cho
Tokyo    101-8535  Japan
Phone: 03-3292-0021 Fax:



Company News
Why Akebia (AKBA), Even With Otsuka Pharma's Big Deal, May Need To Be Acquired 4/27/2017 7:07:32 AM
Otsuka Pharma Believes in Akebia (AKBA), Commits Another $865 Million to Expand Anemia Deal 4/26/2017 5:38:54 AM
Otsuka Pharma Plunks Down $250 Million for Cambridge Biotech Neurovance for Late-Stage Ready ADHD Drug 3/3/2017 7:32:13 AM
Health Canada Approves Otsuka Pharma And Lundbeck (LUN.CO)'s REXULTI (Brexpiprazole) As A Treatment For Schizophrenia In Adults 2/20/2017 6:37:22 AM
Akebia (AKBA) Forges $1B U.S. Deal with Otsuka Pharma on Late-Stage Drug 12/20/2016 6:44:47 AM
Otsuka Pharma Release: FDA Accepts For Review A Supplemental New Drug Application To Expand Labeling Of Abilify Maintena (Aripiprazole) For The Treatment Of Bipolar I Disorder 11/30/2016 10:39:19 AM
Otsuka Pharma Release: ORALTAG (Iohexol), A New Oral Contrast Agent For Abdominal CT Scans, Launched In U.S. 7/5/2016 11:12:33 AM
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial 6/14/2016 6:16:47 AM
Otsuka Pharma Release: 48-Week Data, Presented At The Digestive Disease Week (DDW) Meeting Today, Showed Clinical Benefit With Adacolumn In A Sub-Group Of Refractory Patients With Ulcerative Colitis 5/23/2016 11:04:56 AM
FDA Spurns Otsuka Pharma, Proteus Digital Health's Drug/Device Combo 4/27/2016 6:03:36 AM